For anyone interested in mobile health, the pace of new developments, partnerships, and innovations is, at best, dizzying.
For the busy healthcare professional, its nearly an impossible task to keep abreast of whats happening in this is rapidly growing field.
Our goal at iMedicalApps has always been to help our colleagues navigate this shifting landscape because we believe that mobile health technology is going to transform the way medicine is practiced.
In this weekly series, we will scour through the latest in the mobile health world and pick a few articles that we think are interesting and convey some important development. Be sure to let us know what you think by adding your comments to this post.
This week, we came across some interesting posts on a new mobile-device based system for medical translation services, an update on Mobile MIM in the regulatory world, and efforts by the pharmaceutical industry to leverage mobile technology. Check out the list here.
This press release from Geocom, Inc announces that T-Mobile will be the telecommunications provider for Phrazer, a hand-held mobile device for medical translation services. As the press release points out, language barriers are not only frustrating, but also result in delays in treatment and even medical error.
An article by Bertha Coombs from CNBC that highlights what we’ve known for some time now – namely that tablets, led by the iPad, are becoming an increasingly integral part of day-to-day medical care. In fact, she sites a study from a research firm as stating that approximately 20% of physicians use an iPad, though its not clear that they are implying that these physicians are all using it professionally.
Pharma Goes Mobile: Making The Most Of The App Opportunity
Medical News Today
An interesting article by Andrew Tolve about opportunities and efforts for the pharmaceutical industry in mobile health. In it, he notes opportunities in both customer collaboration (e.g. patient and physician apps) as well as sales/marketting management. And it’s clear the opportunities have not been lost on pharma, as he sites an Ernst and Young report that investment in mobile health technology has increased by nearly 80% in the past year.
Health Canada, on the heels of the FDA’s recent announcement, has now approved Mobile MIM. Interestingly, in this article they note that MIM software also plans to develop a patient portal for mobile devices.